XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
  Hemorrhagic Fevers
  Avian Influenza
  Cholera
  Poliomyelitis
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Avian Influenza Channel
subscribe to Avian Influenza newsletter

World News : Epidemics : Avian Influenza

   DISCUSS   |   EMAIL   |   PRINT
Experimental US vaccine blocks bird flu in mice
Feb 3, 2006, 15:38, Reviewed by: Dr. Priya Saxena

The advantage of the new vaccine is that it could be mass-produced faster than the conventional egg-derived vaccine, which could take six months and four to six billion fertilised eggs to immunise 1.2 billion people worldwide, the researchers said.

 
US researchers have genetically engineered a common cold virus to produce a vaccine they say protects mice from weight loss and death when exposed to the lethal H5N1 bird flu strain, medical journal The Lancet reported Thursday.

The vaccine was produced without using chicken eggs, the conventional growth medium for vaccine production. Eggs could become scarce if the H5N1 infected large swathes of domestic poultry, Mary Hoelscher, the chief researcher on the article, told DPA.

"If you don't have chickens, you don't have eggs," she said.

The antiviral vector the researchers used instead of eggs is a viral tissue culture currently used in making cold and flu immunisations for US military recruits, and is part of the experimental work in developing vaccines against HIV and cancer, Hoelscher said.

Unlike conventional inoculations, which usually contain safe variants of the targeted disease, the vaccine would not contain any form of the H5N1 virus, said Suryaprakash Sambhara of the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.

Clinical trials on humans are the next step, Hoelscher said.

The bird flu virus, currently transmitted among wild and domestic birds, has prompted the mass culling of geese, ducks, chicken and other domestic fowl throughout Asia as health officials try to stem its spread.

The virus has killed at least 72 people infected directly from birds in the past two years, a 50 percent death rate for those infected. But it has not yet spread from human to human.

Researchers are bracing for a worldwide human epidemic, but are at a loss on how they would produce an effective vaccine for the 1.2 billion people they believe would be threatened in a pandemic.

The research described in the Lancet article took place at CDC and at Purdue University in Indiana.

To make the vaccine, the researchers engineered a common cold virus, called the adenovirus, to produce a protein called "haemugglutinin subtype 5", which they said is a component of the H5N1 bird flu virus.

"The protein stimulates the immune system to make the antibodies" against the H5N1 virus, Sambhara said in a telephone interview.

The advantage of the new vaccine is that it could be mass-produced faster than the conventional egg-derived vaccine, which could take six months and four to six billion fertilised eggs to immunise 1.2 billion people worldwide, the researchers said.

The new vaccine would likely get immediate approval by the US Federal Drug Administration in the event of a pandemic, and could be produced in a few months, Sambhara said.
 

- Indo-Asian News Service
 

 
Subscribe to Avian Influenza Newsletter
E-mail Address:

 



Related Avian Influenza News

Are Flu Vaccines Worth the Effort?
Lessons from SARS may help prepare for bird flu
Incomplete vaccination could worsen the spread of avian flu
Scientists aim to thwart use of flu as bioweapon
Pakistani poultry industry demands 10-year tax holiday
Pandemic prevention plan approved for Asia Pacific
H5N1 threat puts human flu back in spotlight
Bird flu hits ninth poultry farm in Pakistan
Conjunctivitis caused by H7 avian influenza in a UK poultry worker
Bird flu strain makes Britain slaughter chicken


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us